REBOVIR

Antivirals; pharmaceutical preparations for treating hepatitis; therapeutic preparations for treating hepatic disease, namely, antiviral nucleosides and Alanine Aminotransferase or Alanine Transaminase normalizations; preparations for normalizing or restoring metabolism; agents for immunity adjustment, namely, oral, transdermal, or injectable antiviral agents; biological preparations for medical purposes; agents affecting digestive organs, namely, agents for restoration of hepatic function; agents affecting the central nervous system, namely, agents for inhibiting virus reproduction; antibiotic preparations; and chemotherapy medicines, namely, pharmaceutical preparations for use in chemotherapy